Zhejiang East Asia Pharmaceutical , Ltd.'s inventory is $360M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Zhejiang East Asia Pharmaceutical , Ltd. (605177.SS) currently reports a inventory of $360M as of September 2026. That compares with $690M in the prior-year period — down 47.5% year over year. Use the charts on this page to explore Zhejiang East Asia Pharmaceutical , Ltd.'s inventory history and peer comparisons.
Zhejiang East Asia Pharmaceutical , Ltd.'s inventory decreased from $690M to $360M — a 47.5% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zhejiang East Asia Pharmaceutical , Ltd. reported $360M in inventory as of September 2026. That compares with $690M in the prior-year period — down 47.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current inventory of $360M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zhejiang East Asia Pharmaceutical , Ltd., and consider following 605177.SS for alerts when major investors trade the stock.
Zhejiang East Asia Pharmaceutical , Ltd. is classified in the Healthcare sector. On inventory, it currently shows $360M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 605177.SS with unrelated industries.